Ambily Banerjee, J&J Innovative Medicine, on Why Representation in Clinical Trials Matters 

Historically, many communities have been underserved and underrepresented in medical research. J&J IM’s Senior Director, Diversity in Clinical Trials, Ambily Banerjee, Ph.D., shares how her personal experiences have reinforced the importance of diversity, equity, and inclusion in clinical trials across the world.